The Neuroblastoma Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Neuroblastoma Market?
The Neuroblastoma Global Market Report 2025 indicates that the neuroblastoma market experienced substantial growth in the recent past. The market value is predicted to rise from $2.97 billion in 2024 to $3.15 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Neuroblastoma Industry?
The Neuroblastoma Global Market is projected to reach a size of $3.93 billion in 2029, with a compound annual growth rate (CAGR) of 5.7%.
Download Your Free Sample of the 2025 Neuroblastoma Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Neuroblastoma Market?
The key drivers in the neuroblastoma market are:
•Increasing government funding for neuroblastoma research and treatment
•Rising incidence of neuroblastoma disease
•Growing emphasis on early detection of the disease
•Advancements in research and better understanding of genetic mutations linked to neuroblastoma
Global Market Segmentation: Identifying Major Neuroblastoma Industry Segments
The neuroblastoma market covered in this report is segmented –
1) By Product Types: Tablets, Vaccines, Other Product Types
2) By Treatment Type: Chemotherapy, Immunotherapy, Other Treatment Types
3) By Distribution Channel: Online, Offline
4) By End-User: Hospitals, Clinics
Subsegments:
1) By Tablets: Oral Chemotherapy Tablets, Targeted Therapy Tablets
2) By Vaccines: Immunotherapy Vaccines, Therapeutic Vaccines
3) By Other Product Types: Injectable Drugs, Monoclonal Antibodies, Cell Therapy Products
Pre-order the 2025 Neuroblastoma Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Neuroblastoma Market?
The key trends in the neuroblastoma market are:
•The development of drugs targeting specific molecular pathways is an emerging trend.
•There is a rising focus on innovations in non-invasive imaging technologies.
•Advancements in gene-editing technologies are increasingly shaping the future of the market.
•There is a growing trend towards personalized treatment and the development of radiolabeled compounds.
Who Are the Top Competitors & Leading Players in the Neuroblastoma Market?
Major players in the neuroblastoma market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Sartorius AG
• Recordati S.p.A
• United Therapeutics Corporation
• BeiGene Ltd.
• MacroGenics Inc.
• Y-mAbs Therapeutics Inc.
• RedHill Biopharma Ltd.
• Clarity Pharmaceuticals Ltd.
• EUSA Pharma (UK) Ltd.
• US WorldMeds LLC
• Healio Inc.
• Ascentage Pharma
• Laboratorio Elea Phoenix S.A
• Curis Inc.
• PersonGen BioTherapeutics (Suzhou) Co. Ltd.
• Essential Pharma S.A
• Cellectar Biosciences Inc.
• Provectus Biopharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the neuroblastoma market in 2024
